If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Alessandra Freyrie is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Azacitidine Medicine & Life Sciences
Comorbidity Medicine & Life Sciences
Survival Medicine & Life Sciences
Cytogenetics Medicine & Life Sciences
Myelodysplastic Syndromes Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Hematologic Neoplasms Medicine & Life Sciences
Dendritic Cells Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2013 2019

  • 8 Citations
  • 2 h-Index
  • 9 Article
1 Citation (Scopus)

Epidemiology and treatment approaches in management of invasive fungal infections in hematological malignancies: Results from a single-centre study

Fracchiolla, N. S., Sciumè, M., Orofino, N., Guidotti, F., Grancini, A., Cavalca, F., Freyrie, A., Goldaniga, M. C., Consonni, D., Mattiello, V., Pettine, L. & Cortelezzi, A., May 1 2019, In : PLoS One. 14, 5, e0216715.

Research output: Contribution to journalArticle

Open Access
Epidemiology
Hematologic Neoplasms
epidemiology
Antigens
Sodium Glutamate
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Dendritic Cells
Neoplasms
Therapeutics

The influence of disease and comorbidity risk assessments on the survival of MDS and oligoblastic AML patients treated with 5-azacitidine: A retrospective analysis in ten centers of the "Rete Ematologica Lombarda"

Molteni, A., Riva, M., Borin, L., Bernardi, M., Pelizzari, A. M., Freyrie, A., Della Porta, M. G., Nichelatti, M., Ravano, E., Quaresmini, G., Mariotti, J., Caramazza, D., Ubezio, M., Guarco, S., Gigli, F., Greco, R., Cairoli, R. & Morra, E., Mar 1 2016, In : Leukemia Research. 42, p. 21-27 7 p.

Research output: Contribution to journalArticle

Azacitidine
Comorbidity
Survival
Cytogenetics
Therapeutics

The influence of disease and comorbidity risk assessments on the survival of MDS and oligoblastic AML patients treated with 5-azacitidine: A retrospective analysis in ten centers of the "Rete Ematologica Lombarda"

Molteni, A., Riva, M., Borin, L., Bernardi, M., Pelizzari, A. M., Freyrie, A., Della Porta, M. G., Nichelatti, M., Ravano, E., Quaresmini, G., Mariotti, J., Caramazza, D., Ubezio, M., Guarco, S., Gigli, F., Greco, R., Cairoli, R. & Morra, E., Mar 1 2016, In : Leukemia Research. 42, p. 21-27 7 p.

Research output: Contribution to journalArticle

Azacitidine
Comorbidity
Survival
Cytogenetics
Therapeutics